tetrandrine has been researched along with Cirrhosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Kong, L; Li, H; Ma, Y; Shen, J; Wu, Z; Zhao, H | 1 |
| Fan, TH; Han, ZF; Li, BC; Li, ZG; Liu, Y; Luo, Y; Qi, XM; Song, MY; Sun, YL; Wang, C; Wang, J; Wang, JX; Yang, PR; Zhang, XR; Zhou, YT | 1 |
| Chang, L; Li, Q; Ma, X; Su, DM | 1 |
| Belke, DD; Duff, HJ; Fedak, PW; Mewhort, HE; Svystonyuk, D; Teng, G; Turnbull, JD | 1 |
| Jiang, S; Jin, Q; Li, X; Lian, LH; Nan, JX; Sun, P; Wu, YL; Zhang, DQ; Zhang, Y; Zhang, YJ | 1 |
| Bian, ZY; Li, H; Liu, C; Shen, DF; Tang, QZ; Wang, L; Yan, L; Zhang, Y; Zhu, LH | 1 |
| Cheng, CC; Chiu, YT; Hsu, YC; Huang, YT; Lin, YL; Wu, CF | 1 |
7 other study(ies) available for tetrandrine and Cirrhosis
| Article | Year |
|---|---|
Tetrandrine inhibits the occurrence and development of frozen shoulder by inhibiting inflammation, angiogenesis, and fibrosis.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Benzylisoquinolines; Bursitis; Collagen Type I; Collagen Type III; Fibrosis; Joint Capsule; Male; Matrix Metalloproteinase 3; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1 | 2021 |
Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages.
Topics: Animals; Benzylisoquinolines; Fibrosis; Inflammasomes; Inflammation; Lung; Macrophages; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Silicosis | 2022 |
[Effects of tetrandrine on proliferation and activation of cardiac fibroblasts].
Topics: Actins; Animals; Benzylisoquinolines; Blotting, Western; Calcium Channel Blockers; Cell Proliferation; Collagen; Collagen Type I; Fibroblasts; Fibrosis; Myocardium; Neoplasm Proteins; Rats; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2018 |
Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis.
Topics: Actins; Animals; Atrial Appendage; Benzylisoquinolines; Calcium; Calcium Channel Blockers; Calcium Chelating Agents; Cardiomyopathies; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Fibrosis; Gels; Humans; Hypertension; Male; Myofibroblasts; Rats, Inbred Dahl; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling.
Topics: Actins; Animals; Apoptosis; Benzylisoquinolines; Caspase 3; Cell Line, Transformed; Drugs, Chinese Herbal; Fibrosis; Hepatic Stellate Cells; Hepatocytes; MAP Kinase Kinase 4; MAP Kinase Kinase Kinases; NF-kappa B; Rats; Signal Transduction; Stephania tetrandra; Tumor Necrosis Factor-alpha | 2016 |
Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzylisoquinolines; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Fibrosis; Heart Failure; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; NFATC Transcription Factors; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recovery of Function; Signal Transduction; Time Factors; Transfection; Ultrasonography; Ventricular Function, Left | 2010 |
Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
Topics: Actins; Alkaloids; Analysis of Variance; Animals; Benzylisoquinolines; Blotting, Western; Cell Line; Dimethylnitrosamine; Fibrosis; Intercellular Adhesion Molecule-1; Liver Cirrhosis, Experimental; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2007 |